Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Spalgais

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Indian Journal of Cancer|December 5, 2017
Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib/erlotinibD Gothi, S Spalgais
Journal of Postgraduate Medicine|June 30, 2015
Pulmonary choriostoma in a case of tuberous sclerosis complexS Spalgais, D Gothi, A K Verma
Journal of Postgraduate Medicine|November 24, 2025
Pleuroparenchymal aspergillus infection in allergic bronchopulmonary aspergillosisS Spalgais, P Sarma, P Mrigpuri, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 30, 2026
Work efficiency at treatment completion for TB: addressing issues beyond bacteriological cureP Sarma, P Mrigpuri, S Spalgais, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Indian Journal of Cancer|December 5, 2017
Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib/erlotinibD Gothi, S Spalgais
Journal of Postgraduate Medicine|June 30, 2015
Pulmonary choriostoma in a case of tuberous sclerosis complexS Spalgais, D Gothi, A K Verma
Journal of Postgraduate Medicine|November 24, 2025
Pleuroparenchymal aspergillus infection in allergic bronchopulmonary aspergillosisS Spalgais, P Sarma, P Mrigpuri, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 30, 2026
Work efficiency at treatment completion for TB: addressing issues beyond bacteriological cureP Sarma, P Mrigpuri, S Spalgais, et al.
Pageof 1